Market open
Bolt Biotherapeutics/$BOLT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Bolt Biotherapeutics
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
Ticker
$BOLT
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
52
ISIN
US0977021049
Website
BOLT Metrics
BasicAdvanced
$13M
-
-$1.66
-
-
Price and volume
Market cap
$13M
52-week high
$0.48
52-week low
$0.30
Average daily volume
117K
Financial strength
Current ratio
3.134
Quick ratio
2.864
Long term debt to equity
47.659
Total debt to equity
52.786
Management effectiveness
Return on assets (TTM)
-34.57%
Return on equity (TTM)
-83.92%
Valuation
Price to revenue (TTM)
3.63
Price to book
0.28
Price to tangible book (TTM)
0.28
Price to free cash flow (TTM)
-0.228
Growth
Revenue change (TTM)
-67.87%
Earnings per share change (TTM)
-0.03%
3-year revenue growth (CAGR)
20.62%
3-year earnings per share growth (CAGR)
-14.25%
BOLT News
AllArticlesVideos
Bolt Biotherapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewsWire·2 days ago
Bolt Biotherapeutics Presents Preclinical Results for Next-Generation Boltbody™ ISACs targeting CEA and PD-L1 at AACR Annual Meeting 2025
GlobeNewsWire·2 weeks ago
Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025
GlobeNewsWire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Bolt Biotherapeutics stock?
Bolt Biotherapeutics (BOLT) has a market cap of $13M as of May 14, 2025.
What is the P/E ratio for Bolt Biotherapeutics stock?
The price to earnings (P/E) ratio for Bolt Biotherapeutics (BOLT) stock is 0 as of May 14, 2025.
Does Bolt Biotherapeutics stock pay dividends?
No, Bolt Biotherapeutics (BOLT) stock does not pay dividends to its shareholders as of May 14, 2025.
When is the next Bolt Biotherapeutics dividend payment date?
Bolt Biotherapeutics (BOLT) stock does not pay dividends to its shareholders.
What is the beta indicator for Bolt Biotherapeutics?
Bolt Biotherapeutics (BOLT) does not currently have a Beta indicator.